STAT+: No more ‘playing God’: How the longevity field is trying to recast its work as serious science

The pharmaceutical industry is still struggling to tackle Alzheimer’s disease. Now, health tech companies are now trying to take a crack at it. […]

Helmy Eltoukhy and AmirAli Talasaz, Guardant’s co-CEOs, discussed the company’s upcoming milestones, how they plan to separate themselves from the competition, and the future of liquid biopsies. […]

SAN FRANCISCO — For months, drugmakers have been pleading with regulators to lower the bar for authorizing antibody drugs for Covid. The virus, they noted, had evolved fast enough to… […]